Search by Drug Name or NDC
NDC 71511-0301-16 QDOLO 5 mg/mL Details
QDOLO 5 mg/mL
QDOLO is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Athena Bioscience, LLC. The primary component is TRAMADOL HYDROCHLORIDE.
MedlinePlus Drug Summary
Tramadol is used to relieve moderate to moderately severe pain. Tramadol extended-release tablets and capsules are only used by people who are expected to need medication to relieve pain around-the-clock. Tramadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
Related Packages: 71511-0301-16Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Tramadol
Product Information
NDC | 71511-0301 |
---|---|
Product ID | 71511-301_0d07f524-71ba-f90f-e063-6394a90a813d |
Associated GPIs | 65100095102005 |
GCN Sequence Number | 081474 |
GCN Sequence Number Description | tramadol HCl SOLUTION 5 MG/ML ORAL |
HIC3 | H3A |
HIC3 Description | OPIOID ANALGESICS |
GCN | 48598 |
HICL Sequence Number | 008317 |
HICL Sequence Number Description | TRAMADOL HCL |
Brand/Generic | Brand |
Proprietary Name | QDOLO |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | tramadol hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/mL |
Substance Name | TRAMADOL HYDROCHLORIDE |
Labeler Name | Athena Bioscience, LLC |
Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
DEA Schedule | CIV |
Marketing Category | NDA |
Application Number | NDA214044 |
Listing Certified Through | 2024-12-31 |
Package
NDC 71511-0301-16 (71511030116)
NDC Package Code | 71511-301-16 |
---|---|
Billing NDC | 71511030116 |
Package | 473 mL in 1 BOTTLE (71511-301-16) |
Marketing Start Date | 2020-09-11 |
NDC Exclude Flag | N |
Pricing Information | N/A |